Sign in to view content

ReCLAIM-2: Phase 2 Trial of Subcutaneous Elamipretide in Patients with Noncentral Geographic Atrophy

Jeffrey S. Heier, MD

Video
Published 2022

Related

Episode 119: 2018 ASRS Annual Meeting Post-Mortem Including Protocol S 5-Year Results
Jayanth Sridhar, MD
Member Podcasts
2018
Beyond Complement: A Novel FAS Inhibition Approach for Neuroprotection in GA
Vaidehi S. Dedania, MD
Updates from the Field
2024
Surgical Implantation of a Biosynthetic RPE Monolayer for Advanced Dry Age-Related Macular Degeneration (AMD): Experience From a Phase 1/2A Study
Amir H Kashani, MD PhD
Annual Meeting Talks
2019

Category: AMD-Non-Neovascular

See more